SENSYNE HEALTH PLC | RNS Reach Story | ||
| Go to market news section | ||
|
Update Following General Election
Oxford, UK; 16 December 2019: Sensyne Health plc (LSE: SENS), the British clinical AI technology company, provides an update following the UK General Election which took place on 12 December 2019.
The outcome of the UK General Election, returning a Conservative government with a significantly increased majority, has now removed a degree of uncertainty from the operating environment for the Company.
Over the past year, the UK government has been moving towards a strategy for the commercial use of anonymised patient data based upon the creation of a sovereign capability at a national level. As announced by the Company on 5 December 2018, Sensyne Health has welcomed this and has formed a portfolio of collaborations with major strategic partners over the past year to enable it to respond positively to these developments.
The new government has signalled that NHS investment and reform will be its top priority and it will now be able to progress with the creation of a national patient data capability.
The Company and its partners are strategically well positioned, with Sensyne's unique NHS partnership model providing a shared financial return back into the NHS.
Lord (Paul) Drayson, CEO of Sensyne Health plc, said:'Sensyne looks forward to working with its NHS partners in 2020 to deliver on this exciting future vision for our National Health Service.'
-ENDS-
For more information please contact:
Sensyne Health (www.sensynehealth.com/) | +44 (0) 330 058 1845 |
Lord (Paul) Drayson, Chief Executive Officer | |
Lorimer Headley, Chief Financial Officer | |
Consilium Strategic Communications | +44 20 3709 5700 |
Mary-Jane Elliott | |
Sukaina Virji | |
Melissa Gardiner | |
About Sensyne Health
Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is an early signatory to the U.K Department of Health and Social Care's 'Initial Code of Conduct for data-driven health and care technology. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L). For more information, please visit: www.sensynehealth.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
| London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
| ©2014London Stock Exchange plc. All rights reserved |
Update Following General Election - RNS
Attachments
- Original document
- Permalink
Disclaimer
Sensyne Health plc published this content on 16 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 December 2019 07:05:06 UTC
